CIENCE CIENCEa graph8 company
+ New search
Your company
24 companies like Angiocrine Bioscience
Angiocrine Bioscience logo

Angiocrine Bioscience

angiocrinebioscience.com
in
Angiocrine Bioscience is a private, clinical-stage biotechnology company developing genetically modified human endothelial cell (E-CEL®) therapies to regenerate tissues, restore function, and treat serious hemato-oncologic, immunologic, and injury-related conditions.
OTGDJFLLMBRSGB
201211-50 emp
San Diego, California
Biotechnology
NAICS 541714
☎1973•••••45
TECH STACK
CloudflareGoogle AnalyticsMySQLNginxPHPShareThisSlider RevolutionWP EngineWordPressYoast SEOjQueryjQuery Migrate

Competitors 11

Angiocrine Bioscience, Inc. campaignconsultative3000 target
Companies like Angiocrine Bioscience, Inc. — Biotechnology, 11-50
“Novel endothelial cell therapy platform for institutions and biopharma teams pursuing advanced regenerative and hematology-focused therapies.”
Launch outbound on autopilot

Personalised emails written for every contact · 97% deliverability · live in 60 seconds

Companies 12
Decision-makers 15
Emails 15
Signals 0

Companies like Angiocrine Bioscience — competitors and alternatives

CompanyWhat they doLocationSizeHiring
Angiocrine Bioscienceangiocrinebioscience.com
JFOTGD
 Angiocrine Bioscience is a private, clinical-stage biotechnology company developing genetically modified human endothelial cell (ESan Diego, California11-50—
Fate Therapeuticsfatetherapeutics.com
VSNSYW
 Fate Therapeutics is a clinical-stage biopharmaceutical company developing a pipeline of iPSC-derived cellular immunotherapies — iSan Diego, California201-1000—
Mesoblastmesoblast.com
TRJHDJ
 Mesoblast is a biotechnology company developing and commercializing allogeneic cellular medicines — off-the-shelf mesenchymal lineMelbourne, VIC51-200—
Pluristempluristem.com
 ———
Athersysathersys.com
ARATVA
 Athersys is a clinical-stage biopharmaceutical company developing a pipeline of differentiated therapeutics — including stem cell Cleveland, Ohio11-50—
 ———
Pluriomicspluriomics.com
 Ncardia is a biotechnology company that manufactures human induced pluripotent stem cell (iPSC)-derived cardiovascular and neural Leiden, Zuid-Holland51-200—
JAAHHG
 ———
Regenerativepharmaregenerativepharma.com
 ———
Cellularnexuscellularnexus.com
 ———
Bioheartbioheart.com
 ———
Celltherapycelltherapy.com
 ———
Run live for more

Agent activity

Done
$fetch_profileangiocrinebioscience.com
Found: Angiocrine Bioscience
$analyze_identityangiocrinebioscience.com
Angiocrine Bioscience is a private, clinical-stage biotechnology company developing genetically modified human endothelial cell (E-CEL®) therapies to regenerate tissues, restore fu
$search_companiescompanies like Angiocrine Bioscience
24 companies
$search_peopledecision-makers
Run live to find contacts & draft emails

Frequently asked questions about Angiocrine Bioscience

What does Angiocrine Bioscience do?

Angiocrine Bioscience is a private, clinical-stage biotechnology company developing genetically modified human endothelial cell (E-CEL®) therapies to regenerate tissues, restore function, and treat serious hemato-oncologic, immunologic, and injury-related conditions.

Who are Angiocrine Bioscience's competitors?

Companies like Angiocrine Bioscience include Fate Therapeutics, Mesoblast, Pluristem, Athersys, Vericel. See the full list of 24 competitors and alternatives above.

How many employees does Angiocrine Bioscience have?

Angiocrine Bioscience has approximately 11-50 employees and is in the Biotechnology industry.

Where is Angiocrine Bioscience headquartered?

Angiocrine Bioscience is headquartered in San Diego, California.

What industry is Angiocrine Bioscience in?

Angiocrine Bioscience operates in the Biotechnology industry.

Who are the decision-makers at Angiocrine Bioscience?

Key decision-makers and buying contacts at Angiocrine Bioscience are listed above, including leaders across executive, finance, sales and operations.